Exosome-based Aβ and tau measures have been reported to be representative of cerebrospinal fluid (CSF) and imaging findings among people with AD, people with mild cognitive impairment (MCI), and age-matched controls (11). The gene discussed is MAPT; the disease is Alzheimer disease.